Alerts will be sent to your verified email
Verify Email
NECLIFE
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Nectar Lifesciences is a key player in the Indian Pharmaceutical Industry, specializing in Global Cephalosporins within Anti Infective Therapeutic segment. The company is expanding globally by entering regulated markets like US and European Union.
Nectar Lifesciences major competitors are Haleos Labs, Everest Organics, Bal Pharma, Tyche Inds, Smruthi Organics, Mangalam Drugs&Org., Lasa Supergenerics.
Market Cap of Nectar Lifesciences is ₹318 Crs.
While the median market cap of its peers are ₹138 Crs.
Nectar Lifesciences seems to be less financially stable compared to its competitors.
Altman Z score of Nectar Lifesciences is 1.88 and is ranked 7 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Dec | Dec | ||||||||||||||||
| Investor Presentation | Sep Dec | |||||||||||||||||
| Conference Call | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
